title: Medium-term survival after primary angioplasty for myocardial infarction complicated by cardiogenic shock after the age of 75 years.
abstract: OBJECTIVE
  To assess mortality in people > or =75 years of age 6 months after myocardial infarction complicated by cardiogenic shock and treated by angioplasty with complete revascularisation and optimal anti-thrombotic treatment; to compare results to those of younger patients with or without shock and to analyse predictive factors for death.
  
  
  METHODS
  The study is based on 1011 consecutive patients with myocardial infarction admitted for primary angioplasty, subdivided into four groups by age and the presence or absence of cardiogenic shock: group 1 (<75 years of age without shock, n=733), group 2 (<75 years of age with shock, n=49), group 3 (> or =75 years of age without shock, n=208) and group 4 (> or =75 years of age with shock, n=20). These four patient groups were compared for mortality rates and predictive factors for in-hospital and 6 month mortality.
  
  
  RESULTS
  In-hospital mortality in groups 1 to 4 was 1.7%, 30.6%, 9.1%, and 70% (p<0.0001) respectively and 6-month mortality was 3.1%, 40%, 16% and 78% (P<0.0001). By univariate analysis renal failure was a predictive factor for death at 6 months in patients without cardiogenic shock (groups 1 and 3), and left ventricular function in patients in group 2. No predictive factors were found in group 4 patients. The independent predictive factors for death at 6 months were: age >75 years of age (P<0.0003), cardiogenic shock (P<0.0001), triple vessel lesions (P<0.01) and creatinine clearance (P=0.004).
  
  
  CONCLUSIONS
  Mortality after angioplasty remains high in people > or =75 years with cardiogenic shock despite all the advances in the management of myocardial infarction. These disappointing results should encourage us to assess the role of surgical revascularisation and circulatory assistance.
authors.affiliation: Institut de cardiologie, Département de cardiologie médicale, Groupe hospitalier Pitié-Salpêtrière, 47-83 boulevard de l'Hôpital, Paris cedex 13.
authors.forename: A
authors.initials: A
authors.lastname: Samadi
authors.forename: C
authors.initials: C
authors.lastname: Le Feuvre
authors.forename: Y
authors.initials: Y
authors.lastname: Allali
authors.forename: J-P
authors.initials: JP
authors.lastname: Collet
authors.forename: O
authors.initials: O
authors.lastname: Barthélémy
authors.forename: F
authors.initials: F
authors.lastname: Beygui
authors.forename: G
authors.initials: G
authors.lastname: Helft
authors.forename: G
authors.initials: G
authors.lastname: Montalescot
authors.forename: J-P
authors.initials: JP
authors.lastname: Metzger
mesh_terms: D000367:Age Factors; D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D005260:Female; D005602:France / Q000453:epidemiology; D017052:Hospital Mortality / Q000639:trends; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000150:complications / Q000401:mortality / Q000628:therapy*; D011379:Prognosis; D012307:Risk Factors; D012770:Shock, Cardiogenic / Q000209:etiology / Q000401:mortality*; D015996:Survival Rate / Q000639:trends